Britt Drogemoller
Britt Drogemoller
Assistant Professor, Department of Biochemistry & Medical Genetics, University of Manitoba
No verified email - Homepage
Cited by
Cited by
Exome sequencing and the management of neurometabolic disorders
M Tarailo-Graovac, C Shyr, CJ Ross, GA Horvath, R Salvarinova, XC Ye, ...
New England Journal of Medicine 374 (23), 2246-2255, 2016
Pharmacogenomic research in South Africa: lessons learned and future opportunities in the rainbow nation
L Warnich, B I Drogemoller, M S Pepper, C Dandara, G EB Wright
Current Pharmacogenomics and Personalized Medicine (Formerly Current …, 2011
Elucidation of CYP2D6 Genetic Diversity in a Unique African Population: Implications for the Future Application of Pharmacogenetics in the Xhosa Population
GEB Wright, DJH Niehaus, BI Drögemöller, L Koen, A Gaedigk, L Warnich
Annals of human genetics 74 (4), 340-350, 2010
Characterization of the genetic profile of CYP2C19 in two South African populations
BI Drögemöller, GEB Wright, DJH Niehaus, L Koen, S Malan, DM Da Silva, ...
Pharmacogenomics 11 (8), 1095-1103, 2010
Length of uninterrupted CAG, independent of polyglutamine size, results in increased somatic instability, hastening onset of Huntington disease
GEB Wright, JA Collins, C Kay, C McDonald, E Dolzhenko, Q Xia, ...
The American Journal of Human Genetics 104 (6), 1116-1126, 2019
Introduction of the AmpliChip CYP450 Test to a South African cohort: a platform comparative prospective cohort study
TM Dodgen, WE Hochfeld, H Fickl, SM Asfaha, C Durandt, P Rheeder, ...
BMC medical genetics 14 (1), 1-15, 2013
Association between SLC16A5 genetic variation and cisplatin-induced ototoxic effects in adult patients with testicular cancer
BI Drögemöller, JG Monzon, AP Bhavsar, AE Borrie, B Brooks, ...
JAMA oncology 3 (11), 1558-1562, 2017
Next-generation sequencing of pharmacogenes: a critical analysis focusing on schizophrenia treatment
BI Drögemöller, GEB Wright, DJH Niehaus, R Emsley, L Warnich
Pharmacogenetics and genomics 23 (12), 666-674, 2013
Characterization of the genetic variation present in CYP3A4 in three South African populations
BI Drogemoller, M Plummer, L Korkie, G Agenbag, A Dunaiski, D Niehaus, ...
Frontiers in Genetics 4, 17, 0
Further investigation of the role of ACYP2 and WFS1 pharmacogenomic variants in the development of cisplatin-induced ototoxicity in testicular cancer patients
BI Drögemöller, B Brooks, C Critchley, JG Monzon, GEB Wright, G Liu, ...
Clinical Cancer Research 24 (8), 1866-1871, 2018
De novo dominant variants affecting the motor domain of KIF1A are a cause of PEHO syndrome
S Langlois, M Tarailo-Graovac, B Sayson, B Drögemöller, A Swenerton, ...
European Journal of Human Genetics 24 (6), 949-953, 2016
Common variation near IRF6 is associated with IFN-β-induced liver injury in multiple sclerosis
K Kowalec, GEB Wright, BI Drögemöller, F Aminkeng, AP Bhavsar, ...
Nature genetics 50 (8), 1081-1085, 2018
Pharmacogenomics of vincristine‐induced peripheral neuropathy implicates pharmacokinetic and inherited neuropathy genes
GEB Wright, U Amstutz, BI Drögemöller, J Shih, SR Rassekh, MR Hayden, ...
Clinical Pharmacology & Therapeutics 105 (2), 402-410, 2019
Glutaminase Deficiency Caused by Short Tandem Repeat Expansion in GLS
ABP van Kuilenburg, M Tarailo-Graovac, PA Richmond, BI Drögemöller, ...
New England Journal of Medicine 380 (15), 1433-1441, 2019
PLPHP deficiency: clinical, genetic, biochemical, and mechanistic insights
DL Johnstone, HH Al-Shekaili, M Tarailo-Graovac, NI Wolf, AS Ivy, ...
Brain 142 (3), 542-559, 2019
Germline de novo mutations in ATP1A1 cause renal hypomagnesemia, refractory seizures, and intellectual disability
KP Schlingmann, S Bandulik, C Mammen, M Tarailo-Graovac, R Holm, ...
The American Journal of Human Genetics 103 (5), 808-816, 2018
Whole-genome resequencing in pharmacogenomics: moving away from past disparities to globally representative applications
BI Drögemöller, GEB Wright, DJH Niehaus, RA Emsley, L Warnich
Pharmacogenomics 12 (12), 1717-1728, 2011
Association of MB-COMT polymorphisms with schizophrenia-susceptibility and symptom severity in an African cohort
GEB Wright, DJH Niehaus, L van der Merwe, L Koen, LJ Korkie, ...
Progress in Neuro-Psychopharmacology and Biological Psychiatry 39 (1), 163-169, 2012
CYP2D6 as a treatment decision aid for ER-positive non-metastatic breast cancer patients: a systematic review with accompanying clinical practice guidelines
BI Drögemöller, GEB Wright, J Shih, JG Monzon, KA Gelmon, CJD Ross, ...
Breast cancer research and treatment 173 (3), 521-532, 2019
Considerations for rare variants in drug metabolism genes and the clinical implications
BI Droegemoeller, GEB Wright, L Warnich
Expert opinion on drug metabolism & toxicology 10 (6), 873-884, 2014
The system can't perform the operation now. Try again later.
Articles 1–20